BioMedomics clinician resources are designed to help healthcare providers stay up-to-date on the state of health conditions detected by our tests. These include the latest facts and statistics as well as links to clinical studies and advocacy organizations. You’ll also find validation studies of our point-of-care technologies.
Many advances have been made in our understanding and treatment of Sickle cell disease (SCD) over the last century, but there is still much we don’t know about basic processes. Globally, significant opportunity exists to improve accessibility of diagnosis and treatment, particularly in under-resourced countries where the majority of people with SCD live. The number of infants born with SCD is growing and survival is low in Africa and India. Accessible screening is crucial for prevention and early treatment to improve and save lives.
Fungal infections tend to be an under-recognized problem despite the millions of people impacted by both common and serious variants worldwide. A major challenge in the treatment of common fungal infections is increasing resistance to antifungal therapies. Lack of efficient diagnostic tools compound the problem as clinicians often prescribe medications in the absence of a definitive diagnosis. The rise in the number of individuals with compromised immune systems and the limitations of existing antifungal treatments make invasive fungal infections a growing concern.